NeoGenomics Schedules Its Q1 2008 Earnings Release for May 7, 2008

By NeoGenomics, Inc.

    The Company has scheduled a webcast and conference call to discuss their
Q1 08 results on May 7, 2008, at 11:00 AM EDT.  Interested investors should
dial (877) 407-0778 (domestic) and (201) 689-8565 (international) at least
five minutes prior to the call.  A replay of the conference call will be
available until 11:59 PM on May 21, 2008 and can be accessed by dialing
(877) 660-6853 (domestic) and (201) 612-7415 (international).  The playback
account number is 286 and the playback conference ID Number/PIN Number is
284549.  The web-cast may be accessed under the Investor Relations section of
our website at http://www.neogenomics.org or at the website of our Investor
Relations firm, Hawk Associates, at
http://www.hawkassociates.com/ngnmmore.aspx or at
http://www.vcall.com/IC/CEPage.asp?ID=129616.  An archive of the web-cast will
be available until 11:59 PM EDT on August 8, 2008.

About NeoGenomics, Inc.

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, hospitals and other reference laboratories throughout the United States. For additional information about NeoGenomics, visit http://www.neogenomics.org.

Interested parties can also access additional investor relations material from the American Microcap Institute at http://www.americanmicrocapinstitute.com/ngnm/ or from Hawk Associates at http://www.hawkassociates.com. An investment profile about NeoGenomics may be found at http://www.hawkassociates.com/ngnmprofile.aspx .

Forward Looking Statements

Except for historical information, all of the statements, expectations and assumptions contained in the foregoing are forward-looking statements. These forward looking statements involve a number of risks and uncertainties that could cause actual future results to differ materially from those anticipated in the forward looking statements, Actual results could differ materially from such statements expressed or implied herein. Factors that might cause such a difference include, among others, the company's ability to continue gaining new customers, offer new types of tests, and otherwise implement its business plan. As a result, this press release should be read in conjunction with the company's periodic filings with the SEC.

SOURCE NeoGenomics, Inc.